OPEN-ANGLE GLAUCOMA
Clinical trials for OPEN-ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new OPEN-ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for OPEN-ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New glaucoma surgery under the microscope: does it lower eye pressure Long-Term?
Disease control ENROLLING_BY_INVITATIONThis study follows 300 adults with open angle glaucoma who had surgery using the CycloPen system to lower eye pressure. Researchers will check if eye pressure drops by at least 20% and track any side effects for two years after surgery. The goal is to see how safe and effective t…
Matched conditions: OPEN-ANGLE GLAUCOMA
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New eye injection could ease glaucoma pressure
Disease control OngoingThis study tests an experimental drug injection (AGN-193408 SR) in 100 adults with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure, which is the main way to control these conditions. Participants stop their usual eye drops during the …
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
New eye surgery aims to lower glaucoma pressure without lifelong drops
Disease control ENROLLING_BY_INVITATIONThis study follows 300 people with open-angle glaucoma who have a special surgery called bio-reinforced canaloplasty. The surgery is designed to help fluid drain from the eye, lowering pressure inside the eye. Researchers will check how much the pressure drops and how long the ef…
Matched conditions: OPEN-ANGLE GLAUCOMA
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
New eye drop shows promise for glaucoma patients in china
Disease control OngoingThis study tests a new eye drop called DE-117B for people with open-angle glaucoma or high eye pressure. It aims to see if the drops safely lower eye pressure over time. About 345 adults in China will use the drops daily for at least 4 weeks, with some receiving an active compara…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE3 • Sponsor: Santen Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Glaucoma implant study aims to save sight in china
Disease control OngoingThis study tests the XEN45 implant, a tiny device placed in the eye to lower pressure in people with open-angle glaucoma. About 120 adults in China will receive either the XEN45 implant or standard surgery, and researchers will track side effects and eye pressure for 5 years. The…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated May 22, 2026 13:54 UTC